IDH mutation in glioma: molecular mechanisms and potential therapeutic targets

Isocitrate dehydrogenase (IDH) enzymes catalyse the oxidative decarboxylation of isocitrate and therefore play key roles in the Krebs cycle and cellular homoeostasis. Major advances in cancer genetics over the past decade have revealed that the genes encoding IDHs are frequently mutated in a variety...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	British journal of cancer Ročník 122; číslo 11; s. 1580 - 1589
Hlavní autoři:	Han, Sue, Liu, Yang, Cai, Sabrina J., Qian, Mingyu, Ding, Jianyi, Larion, Mioara, Gilbert, Mark R., Yang, Chunzhang
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London Nature Publishing Group UK 26.05.2020 Nature Publishing Group
Témata:	631/208/737 631/80 Acute myeloid leukemia Animals Biomedical and Life Sciences Biomedicine Brain Neoplasms - genetics Cancer Research Cell Transformation, Neoplastic - genetics Cholangiocarcinoma Chondrosarcoma Decarboxylation Drug Resistance Epidemiology Glioma Glioma - genetics Humans Isocitrate dehydrogenase Isocitrate Dehydrogenase - genetics Leukemia Molecular Medicine Molecular modelling Mutants Mutation Oncology Review Review Article Therapeutic applications Thyroid cancer Thyroid carcinoma Tricarboxylic acid cycle Tumorigenesis
ISSN:	0007-0920, 1532-1827, 1532-1827
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!